Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perospirone for adolescent bipolar depression
NCT04826510Phase 4Unknown
- Sponsor
- Shanghai Mental Health Center
- Start
- Nov 2020
- Primary completion
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of perospirone in bipolar disorder (BD), sponsored by Shanghai Mental Health Center. Status: unknown.
02
Drugs
perospirone
03
Conditions
bipolar disorder (BD)
Beyond the preview
Go deeper on NCT04826510.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04826510.